American College of Clinical Pharmacology

American College of Clinical Pharmacology American College of Clinical Pharmacology (ACCP) is a non-profit membership association with a 40+ year history of providing exceptional interdisciplinary,

Founded in 1969 by a group of eminent physicians, the College today consists of a full spectrum of healthcare professionals who remain dedicated to advancing clinical pharmacology with the goal of providing exceptional patient care. As an organization whose primary role is education, the College does not concentrate on any one aspect of the discipline. Rather, the College seeks to address the edu

Founded in 1969 by a group of eminent physicians, the College today consists of a full spectrum of healthcare professionals who remain dedicated to advancing clinical pharmacology with the goal of providing exceptional patient care. As an organization whose primary role is education, the College does not concentrate on any one aspect of the discipline. Rather, the College seeks to address the edu

Operating as usual

Thank you to the Attendees, Faculty Speakers, Sponsors, Poster Presenters and volunteers of the #2021ACCP Annual Meeting...
09/17/2021

Thank you to the Attendees, Faculty Speakers, Sponsors, Poster Presenters and volunteers of the #2021ACCP Annual Meeting! We could not have done this without and are pleased we were able to offer you another outstanding, educational clinical pharmacology event. We would also like to take this time to acknowledge the 2021 Annual Meeting Program Committee Co-chaired by Drs. Navin Goyal and Arun Ram on a cutting-edge scientific meeting!

We hope to see everyone at the #2022ACCP Annual Meeting in Bethesda, MD, September 25 - 27, 2022!

Thank you to the Attendees, Faculty Speakers, Sponsors, Poster Presenters and volunteers of the #2021ACCP Annual Meeting! We could not have done this without and are pleased we were able to offer you another outstanding, educational clinical pharmacology event. We would also like to take this time to acknowledge the 2021 Annual Meeting Program Committee Co-chaired by Drs. Navin Goyal and Arun Ram on a cutting-edge scientific meeting!

We hope to see everyone at the #2022ACCP Annual Meeting in Bethesda, MD, September 25 - 27, 2022!

Welcome to the last day of the #2021ACCP Virtual Annual Meeting! We are in the homestretch and will finish strong with t...
09/17/2021

Welcome to the last day of the #2021ACCP Virtual Annual Meeting! We are in the homestretch and will finish strong with two Recognition Award Winner presentations, Symposia 11 – 14 and closing remarks from Dr. Donald E. Mager, ACCP President. We look forward to seeing everyone soon!

This is your last chance to register for the meeting to have access to On Demand content for one year! https://bit.ly/2X5rnjQ

Welcome to the last day of the #2021ACCP Virtual Annual Meeting! We are in the homestretch and will finish strong with two Recognition Award Winner presentations, Symposia 11 – 14 and closing remarks from Dr. Donald E. Mager, ACCP President. We look forward to seeing everyone soon!

This is your last chance to register for the meeting to have access to On Demand content for one year! https://bit.ly/2X5rnjQ

Thank you to our #2021ACCP Virtual Annual Meeting Award Winners for taking a picture with your award! It brings us joy s...
09/16/2021

Thank you to our #2021ACCP Virtual Annual Meeting Award Winners for taking a picture with your award! It brings us joy seeing you holding them. Congratulations again to all!

We would like to take this time to thank the Sponsors of the #2021ACCP Virtual Annual Meeting noted below, in addition t...
09/16/2021

We would like to take this time to thank the Sponsors of the #2021ACCP Virtual Annual Meeting noted below, in addition to Pfizer Inc for the unrestricted educational grant! We appreciate your support and look forward to working with you again at the #2022ACCP Annual Meeting!

We would like to take this time to thank the Sponsors of the #2021ACCP Virtual Annual Meeting noted below, in addition to Pfizer Inc for the unrestricted educational grant! We appreciate your support and look forward to working with you again at the #2022ACCP Annual Meeting!

Welcome to Day 4 of the #2021ACCP Virtual Annual Meeting! We have a great day ahead of us which begins with two Recognit...
09/16/2021

Welcome to Day 4 of the #2021ACCP Virtual Annual Meeting! We have a great day ahead of us which begins with two Recognition Award Winner presentations, Symposia 8 - 10, the Regulatory Session: Clinical Pharmacology Regulatory Considerations for Recent Oncology Approvals and concluding with the ACCP Virtual Happy Hour. Enjoy the day and let us know what you enjoy most.

Unable to attend the meeting Live? Register today and get access to the On Demand recordings for one year! https://bit.ly/2X5rnjQ

Welcome to Day 4 of the #2021ACCP Virtual Annual Meeting! We have a great day ahead of us which begins with two Recognition Award Winner presentations, Symposia 8 - 10, the Regulatory Session: Clinical Pharmacology Regulatory Considerations for Recent Oncology Approvals and concluding with the ACCP Virtual Happy Hour. Enjoy the day and let us know what you enjoy most.

Unable to attend the meeting Live? Register today and get access to the On Demand recordings for one year! https://bit.ly/2X5rnjQ

Please join us in congratulating the #2021ACCP Virtual Annual Meeting Abstract Award Winners & Member-Get-a-Member Award...
09/15/2021

Please join us in congratulating the #2021ACCP Virtual Annual Meeting Abstract Award Winners & Member-Get-a-Member Award Winner recognized below! A big thank you to our Poster Judges Drs. Claude Abdallah, Vikram Arya, Michael Fossler and Laurent Vernillet for their support.

New Member Abstract Award Winner: Spinel Karas, PharmD
Wayne A. Colburn Memorial Award Winner: Lori Ellezian, BS, MS
Member-Get-a-Member Award Winner: Simon Berger, MS

Please join us in congratulating the #2021ACCP Virtual Annual Meeting Abstract Award Winners & Member-Get-a-Member Award Winner recognized below! A big thank you to our Poster Judges Drs. Claude Abdallah, Vikram Arya, Michael Fossler and Laurent Vernillet for their support.

New Member Abstract Award Winner: Spinel Karas, PharmD
Wayne A. Colburn Memorial Award Winner: Lori Ellezian, BS, MS
Member-Get-a-Member Award Winner: Simon Berger, MS

Reminder to all ACCP Members...Applications for the 2022 Leadership Development Program are being accepted until Septemb...
09/15/2021

Reminder to all ACCP Members...Applications for the 2022 Leadership Development Program are being accepted until September 30th! This program is structured to enhance your leadership skills and create opportunities for potential future ACCP Leaders. For more info on the application requirements, please visit https://bit.ly/3CQcSAm

Reminder to all ACCP Members...Applications for the 2022 Leadership Development Program are being accepted until September 30th! This program is structured to enhance your leadership skills and create opportunities for potential future ACCP Leaders. For more info on the application requirements, please visit https://bit.ly/3CQcSAm

Gilead Sciences, Inc is an ACCP Platinum Sponsor of the #2021ACCP Virtual Annual Meeting and are supporting the meeting ...
09/15/2021

Gilead Sciences, Inc is an ACCP Platinum Sponsor of the #2021ACCP Virtual Annual Meeting and are supporting the meeting during Symposium 5 today at 11:00 AM ET and on Friday in Symposium 14. They are seeking talented clinical pharmacologists with a quantitative & innovative mindset across all career levels. Check out their opportunities in the ACCP Job Center.

Thank you Gilead Sciences, Inc for your generous support!

Gilead Sciences, Inc is an ACCP Platinum Sponsor of the #2021ACCP Virtual Annual Meeting and are supporting the meeting during Symposium 5 today at 11:00 AM ET and on Friday in Symposium 14. They are seeking talented clinical pharmacologists with a quantitative & innovative mindset across all career levels. Check out their opportunities in the ACCP Job Center.

Thank you Gilead Sciences, Inc for your generous support!

Welcome to Day 3 of the #2021ACCP Virtual Annual Meeting!! We have another exciting day ahead of us which begins with th...
09/15/2021

Welcome to Day 3 of the #2021ACCP Virtual Annual Meeting!! We have another exciting day ahead of us which begins with the STEP Podium Presentations from Drs. Aaron Devanathan, Kendra Radtke and Amir Sarayani, the Invited Keynote presented by Dr. Elaine Abrams, a Networking Roundtable presented by Nuventra, Inc, Symposia 4 - 7 and ending with the ISoP/SIG Outreach Event. We hope you enjoy the sessions.

The Symposia will be available On Demand for all registered Attendees for one year. It's not too late to register to get access to an outstanding educational and scientific event for the clinical pharmacology community! https://bit.ly/2X5rnjQ

Welcome to Day 3 of the #2021ACCP Virtual Annual Meeting!! We have another exciting day ahead of us which begins with the STEP Podium Presentations from Drs. Aaron Devanathan, Kendra Radtke and Amir Sarayani, the Invited Keynote presented by Dr. Elaine Abrams, a Networking Roundtable presented by Nuventra, Inc, Symposia 4 - 7 and ending with the ISoP/SIG Outreach Event. We hope you enjoy the sessions.

The Symposia will be available On Demand for all registered Attendees for one year. It's not too late to register to get access to an outstanding educational and scientific event for the clinical pharmacology community! https://bit.ly/2X5rnjQ

Clinical Pharmacology in Drug Development, September 2021 Volume 10, Issue 9 is now available! https://bit.ly/39XjxMS*Re...
09/14/2021

Clinical Pharmacology in Drug Development, September 2021 Volume 10, Issue 9 is now available! https://bit.ly/39XjxMS

*Review*
Update on ICH E14/S7B Cardiac Safety Regulations: The Expanded Role of Preclinical Assays and the “Double‐Negative” Scenario
Robert M. Lester
Pages: 964-973 | First Published: 31 July 2021

*Articles*
Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration
Charles Frost, Samira Garonzik, Andrew Shenker, Yu Chen Barrett, Frank LaCreta
Pages: 974-984 | First Published: 02 August 2021

Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants
Rajendra P. Singh, Kimberly Adkison, Allen Wolstenholme, Judy Hopking, Brian Wynne
Pages: 985-993 | First Published: 15 July 2021

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
Helen Timmis, Tim Van Kaem, Julie Desrivot, Sonia Dupont, Luc Meuleners, Johan Beetens, Eric Helmer, Eva Santermans, Silke Huettner
Pages: 994-1006 | First Published: 07 May 2021

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
Julie Desrivot, Tim Van Kaem, Lisa Allamassey, Eric Helmer
Pages: 1007-1017 | First Published: 06 May 2021

A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe
Irina Cherniakov, Orit Cohen-Barak, Ryan Tiver, Michael Gillespie, Yoel Kessler, Maria Gutierrez, Michele Rasamoelisolo, Shawn Li, Honglue Shen, Hussein Hallak, Pippa S. Loupe, Michael Smith, Laura Rabinovich-Guilatt, Ofer Spiegelstein
Pages: 1018-1027 | First Published: 07 January 2021

Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products
Steven Zhang, Shu Jin, Celina Griffin, Zhongling Feng, Jianchang Lin, Mike Baratta, Rachael Brake, Karthik Venkatakrishnan, Neeraj Gupta
Pages: 1028-1043 | First Published: 12 June 2021

Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK‐788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers
Steven Zhang, Shu Jin, Celina Griffin, Zhongling Feng, Jianchang Lin, Karthik Venkatakrishnan, Neeraj Gupta
Pages: 1044-1053 | First Published: 19 June 2021

Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate)
Noelia Nebot, Christina S. Won, Victor Moreno, Eva Muñoz-Couselo, Dung-Yang Lee, Eduard Gasal, Emmanuel Bouillaud
Pages: 1054-1063 | First Published: 01 May 2021

Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route
Jahnavi Kharidia, Eleanor M. Howgate, Celine M. Laffont, Yongzhen Liu, Malcolm A. Young
Pages: 1064-1074 | First Published: 22 March 2021

Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice
Yi Shuan Wu, Richie Khanna, Virginia Schmith, Yi Lun, Jin-Song Shen, Anadina Garcia, Leo Dungan, Anthony Perry, Lukas Martin, Pai-Chi Tsai, Rick Hamler, Anibh M. Das, Raphael Schiffmann, Franklin K. Johnson
Pages: 1075-1088 | First Published: 19 April 2021

Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females
Ishani Landry, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Satish Dayal, Margaret Moline, Larisa Reyderman
Pages: 1089-1098 | First Published: 09 June 2021

A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single‐Dose, Phase 1 Crossover Trial
Ramesh Boinpally, Brian McNamee, Li Yao, Matthew Butler, Danielle McGeeney, Lisa Borbridge, Antonia Periclou
Pages: 1099-1107 | First Published: 04 May 2021

Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer
Song Mu, Daniel Palmer, Richard Fitzgerald, Claudia Andreu-Vieyra, Heather Zhang, Zhiyu Tang, Dan Su, Srikumar Sahasranaman
Pages: 1108-1120 | First Published: 19 April 2021
#pharmacology #drugdevelopment

Clinical Pharmacology in Drug Development, September 2021 Volume 10, Issue 9 is now available! https://bit.ly/39XjxMS

*Review*
Update on ICH E14/S7B Cardiac Safety Regulations: The Expanded Role of Preclinical Assays and the “Double‐Negative” Scenario
Robert M. Lester
Pages: 964-973 | First Published: 31 July 2021

*Articles*
Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration
Charles Frost, Samira Garonzik, Andrew Shenker, Yu Chen Barrett, Frank LaCreta
Pages: 974-984 | First Published: 02 August 2021

Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants
Rajendra P. Singh, Kimberly Adkison, Allen Wolstenholme, Judy Hopking, Brian Wynne
Pages: 985-993 | First Published: 15 July 2021

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
Helen Timmis, Tim Van Kaem, Julie Desrivot, Sonia Dupont, Luc Meuleners, Johan Beetens, Eric Helmer, Eva Santermans, Silke Huettner
Pages: 994-1006 | First Published: 07 May 2021

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
Julie Desrivot, Tim Van Kaem, Lisa Allamassey, Eric Helmer
Pages: 1007-1017 | First Published: 06 May 2021

A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe
Irina Cherniakov, Orit Cohen-Barak, Ryan Tiver, Michael Gillespie, Yoel Kessler, Maria Gutierrez, Michele Rasamoelisolo, Shawn Li, Honglue Shen, Hussein Hallak, Pippa S. Loupe, Michael Smith, Laura Rabinovich-Guilatt, Ofer Spiegelstein
Pages: 1018-1027 | First Published: 07 January 2021

Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products
Steven Zhang, Shu Jin, Celina Griffin, Zhongling Feng, Jianchang Lin, Mike Baratta, Rachael Brake, Karthik Venkatakrishnan, Neeraj Gupta
Pages: 1028-1043 | First Published: 12 June 2021

Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK‐788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers
Steven Zhang, Shu Jin, Celina Griffin, Zhongling Feng, Jianchang Lin, Karthik Venkatakrishnan, Neeraj Gupta
Pages: 1044-1053 | First Published: 19 June 2021

Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate)
Noelia Nebot, Christina S. Won, Victor Moreno, Eva Muñoz-Couselo, Dung-Yang Lee, Eduard Gasal, Emmanuel Bouillaud
Pages: 1054-1063 | First Published: 01 May 2021

Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route
Jahnavi Kharidia, Eleanor M. Howgate, Celine M. Laffont, Yongzhen Liu, Malcolm A. Young
Pages: 1064-1074 | First Published: 22 March 2021

Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice
Yi Shuan Wu, Richie Khanna, Virginia Schmith, Yi Lun, Jin-Song Shen, Anadina Garcia, Leo Dungan, Anthony Perry, Lukas Martin, Pai-Chi Tsai, Rick Hamler, Anibh M. Das, Raphael Schiffmann, Franklin K. Johnson
Pages: 1075-1088 | First Published: 19 April 2021

Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females
Ishani Landry, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Satish Dayal, Margaret Moline, Larisa Reyderman
Pages: 1089-1098 | First Published: 09 June 2021

A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single‐Dose, Phase 1 Crossover Trial
Ramesh Boinpally, Brian McNamee, Li Yao, Matthew Butler, Danielle McGeeney, Lisa Borbridge, Antonia Periclou
Pages: 1099-1107 | First Published: 04 May 2021

Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer
Song Mu, Daniel Palmer, Richard Fitzgerald, Claudia Andreu-Vieyra, Heather Zhang, Zhiyu Tang, Dan Su, Srikumar Sahasranaman
Pages: 1108-1120 | First Published: 19 April 2021
#pharmacology #drugdevelopment

Another big thank you to the Poster Presenters and Early-stage Professional Event Speakers, Group Leaders & Volunteers l...
09/14/2021

Another big thank you to the Poster Presenters and Early-stage Professional Event Speakers, Group Leaders & Volunteers listed below. It was exciting to see the activity yesterday during each Poster Session and the active participation during the Early-stage Professional Event: Finding Your Sense of Community at ACCP. Again, thank you for your support in making the #2021ACCP Virtual Annual Meeting a place where everyone is welcome at every stage of their career!

ESP Event Speakers/Volunteers/Group Leaders: Drs. Jonathan Constance, Oliver Grundmann, Kunal Jhunjhunwala, Stephan Schmidt, Pooja Manchandani, JJ Bhongsatiern, Alexander Prokopienko, Joseph S. Bertino Jr, Michael Fossler, Neeraj Gupta, Natella Rakhmanina and John van den Anker.

Another big thank you to the Poster Presenters and Early-stage Professional Event Speakers, Group Leaders & Volunteers listed below. It was exciting to see the activity yesterday during each Poster Session and the active participation during the Early-stage Professional Event: Finding Your Sense of Community at ACCP. Again, thank you for your support in making the #2021ACCP Virtual Annual Meeting a place where everyone is welcome at every stage of their career!

ESP Event Speakers/Volunteers/Group Leaders: Drs. Jonathan Constance, Oliver Grundmann, Kunal Jhunjhunwala, Stephan Schmidt, Pooja Manchandani, JJ Bhongsatiern, Alexander Prokopienko, Joseph S. Bertino Jr, Michael Fossler, Neeraj Gupta, Natella Rakhmanina and John van den Anker.

Address

21750 Red Rum Dr, Ste 137
Ashburn, VA
20147

General information

ACCP is a member-driven/member-focused organization that provides accredited continuing education to healthcare professionals. ACCP also publishes The Journal of Clinical Pharmacology and will soon publish the eJournal Clinical Pharmacology in Drug Development.

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

(571) 291-3493

Products

High-quality CME & CPE live, webinar and enduring events; The Journal of Clinical Pharmacology and Clinical Pharmacology in Drug Development

Alerts

Be the first to know and let us send you an email when American College of Clinical Pharmacology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to American College of Clinical Pharmacology:

Nearby non profit organizations


Other Nonprofit Organizations in Ashburn

Show All